Digital deals in life sciences – what makes them different?

Are you ready for a digital-first future in life sciences? This report explores the challenges and opportunities presented by digital deals.

Essential reading for healthcare and technology dealmakers seeking to navigate an unfamiliar terrain of transactions involving artificial intelligence, machine learning and big data, our report provides insights into differences between digital and traditional deals in key areas including corporate culture, data privacy, intellectual property, asset valuation, due diligence and deal structuring.

To receive a copy, fill in your details in the form below.